Experts at the Paris Cardiovascular Research Center (PARCC) have designed an artificial intelligence-based system to predict kidney allograft survival. This model was validated in an observational multicohort study in Europe, the U.S. and South America, as well as randomized trials and results were published in The Lancet Digital Health.